The manufacturer's Panorama CS12 is a dedicated hardware controller for Logic that's described by Nektar's Product Manager Tim Chandler as "a completely new take" on the format. CS12 is a channel ...

Nektar shed 70% of its workforce as a result and refocused its R&D on NKTR-358, an IL-2 conjugate regulatory T cell stimulator for inflammatory conditions like lupus and atopic dermatitis ...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders.

Nektar Therapeutics is not owned by hedge funds ... suggesting that no single shareholder has significant control over the company.